Developed at SMART, the device can deliver controlled amounts of agrochemicals to specific plant tissues for research and could one day be used to improve crop quality and disease management.
He conducted groundbreaking research into auditory physiology at MIT and Harvard Medical School, and was the founding director of the Eaton-Peabody Laboratories at Mass Eye and Ear.
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.